Search research articles
Contact Us
Filters
Showing results (91-100 of 97) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 97 results.
Journal of Viral Hepatitis
|
March 31, 2016
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
R J Harris, N K Martin, E Rand, et al.
Lancet (London, England)
|
November 2, 1996
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
L Grellier, D Mutimer, M Ahmed, et al.
Postgraduate Medical Journal
|
August 9, 2013
Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice
M J Armstrong, C Corbett, J Hodson, et al.
Public Health
|
July 13, 2026
Reviewing hepatitis B virus (HBV)-related mortality in Birmingham (2018-2023): The impact of late diagnosis
S Santharam, S Croxford, D Mutimer, et al.
Journal of Hepatology
|
April 20, 1999
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
D Mutimer, D Pillay, E Dragon, et al.
Alimentary Pharmacology & Therapeutics
|
August 5, 2015
Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)
S Zeuzem, R Flisiak, J M Vierling, et al.
The British Journal of Surgery
|
February 16, 2022
Outcomes of normothermic machine perfusion of liver grafts in repeat liver transplantation (NAPLES initiative)
A Hann, H Lembach, A Nutu, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 97) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 97 results.
Journal of Viral Hepatitis
|
March 31, 2016
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
R J Harris, N K Martin, E Rand, et al.
Lancet (London, England)
|
November 2, 1996
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
L Grellier, D Mutimer, M Ahmed, et al.
Postgraduate Medical Journal
|
August 9, 2013
Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice
M J Armstrong, C Corbett, J Hodson, et al.
Public Health
|
July 13, 2026
Reviewing hepatitis B virus (HBV)-related mortality in Birmingham (2018-2023): The impact of late diagnosis
S Santharam, S Croxford, D Mutimer, et al.
Journal of Hepatology
|
April 20, 1999
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
D Mutimer, D Pillay, E Dragon, et al.
Alimentary Pharmacology & Therapeutics
|
August 5, 2015
Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)
S Zeuzem, R Flisiak, J M Vierling, et al.
The British Journal of Surgery
|
February 16, 2022
Outcomes of normothermic machine perfusion of liver grafts in repeat liver transplantation (NAPLES initiative)
A Hann, H Lembach, A Nutu, et al.
Page
of 10